within Pharmacolibrary.Drugs.ATC.A;

model A11HA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.25,
    adminDuration  = 600,
    adminMass      = 0.3,
    adminCount     = 1,
    Vd             = 0.00017,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Biotin, also known as vitamin B7 or vitamin H, is a water-soluble B-complex vitamin essential for various metabolic processes in the human body, particularly in the synthesis of fatty acids, amino acids, and glucose. It is primarily used as a dietary supplement to prevent or treat biotin deficiency, which is rare, and is sometimes used in hair, skin, and nail health products. Biotin is approved and widely available as an over-the-counter supplement.</p><h4>Pharmacokinetics</h4><p>Estimated typical PK parameters for healthy adult individuals after oral administration based on limited published data and general pharmacokinetic properties of water-soluble vitamins.</p><h4>References</h4><ol><li><p>Peyro Saint Paul, L, et al., &amp; Defer, GL (2016). Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. <i>Expert opinion on drug metabolism &amp; toxicology</i> 12(3) 327–344. DOI:<a href=&quot;https://doi.org/10.1517/17425255.2016.1136288&quot;>10.1517/17425255.2016.1136288</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26699811/&quot;>https://pubmed.ncbi.nlm.nih.gov/26699811</a></p></li><li><p>Cui, Z, et al., &amp; Mao, S (2021). Design of biotin decorated enterocyte targeting muco-inert nanocomplexes for enhanced oral insulin delivery. <i>Carbohydrate polymers</i> 261 117873–None. DOI:<a href=&quot;https://doi.org/10.1016/j.carbpol.2021.117873&quot;>10.1016/j.carbpol.2021.117873</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33766360/&quot;>https://pubmed.ncbi.nlm.nih.gov/33766360</a></p></li><li><p>Sharma, T, et al., &amp; Singh, B (2021). QbD-Steered Development of Biotin-Conjugated Nanostructured Lipid Carriers for Oral Delivery of Chrysin: Role of Surface Modification for Improving Biopharmaceutical Performance. <i>Colloids and surfaces. B, Biointerfaces</i> 197 111429–None. DOI:<a href=&quot;https://doi.org/10.1016/j.colsurfb.2020.111429&quot;>10.1016/j.colsurfb.2020.111429</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33130524/&quot;>https://pubmed.ncbi.nlm.nih.gov/33130524</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A11HA05;
